64 reports of this reaction
6.7% of all PHENOBARBITAL SODIUM reports
#1 most reported adverse reaction
SEIZURE is the #1 most commonly reported adverse reaction for PHENOBARBITAL SODIUM, manufactured by BPI Labs LLC. There are 64 FDA adverse event reports linking PHENOBARBITAL SODIUM to SEIZURE. This represents approximately 6.7% of all 956 adverse event reports for this drug.
Patients taking PHENOBARBITAL SODIUM who experience seizure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SEIZURE is moderately reported among PHENOBARBITAL SODIUM users, representing a notable but not dominant share of adverse events.
In addition to seizure, the following adverse reactions have been reported for PHENOBARBITAL SODIUM:
The following drugs have also been linked to seizure in FDA adverse event reports:
SEIZURE has been reported as an adverse event in 64 FDA reports for PHENOBARBITAL SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
SEIZURE accounts for approximately 6.7% of all adverse event reports for PHENOBARBITAL SODIUM, making it one of the most commonly reported side effect.
If you experience seizure while taking PHENOBARBITAL SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.